doi:10.1016/j.bcp.2017.11.007 PubMed: 29155147 Kraus D, Yang Q, Kong D, et al
Yes, it pairs well with other therapies, such as IV drips or additional vitamin injections, to maximize your health benefits
Any references to insulin-like growth factor, growth-related pathways, or metabolic endpoints are provided for scientific context only
Heres what you need to know: Mechanism: Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) through beta-3 adrenergic receptor modulation and direct adipocyte interaction Primary Benefit: Enhanced fat metabolism and body composition improvement without affecting blood sugar or insulin sensitivity Administration: Subcutaneous injection or oral administration, typically daily Typical Dosing: 250-500 mcg daily via injection, or higher doses (1-2 mg) orally, administered in morning on empty stomach Results Timeline: Initial metabolic changes within 2-4 weeks, visible body composition changes in 8-12 weeks Best For: Individuals seeking metabolic support, stubborn fat reduction, and body recomposition without growth hormone effects Safety Profile: Clinical trials with over 900 participants demonstrated excellent tolerability with no serious adverse events Comparison: More selective than full-length growth hormone, targeting only fat metabolism without affecting glucose regulation or IGF-1 levels The following guide provides complete details on AOD-9604 s metabolic support process, from molecular mechanisms to practical protocols
For professionals only
Abbreviations MetS: Metabolic syndrome IGF-1: Insulin-like growth factor CVD: Cardiovascular disease T2D: Type 2 diabetes RAS: Protooncogene protein P21 NAFLD: Non-alcoholic fatty liver disease OSA: Obstructive sleep apnea HDL: High density lipoprotein TG: Triglyceride PI3K: Phosphatidylinositol-4,5-bisphosphate 3-kinase AKT: Protein kinase B GLUT: Glucose transporter FA: Fatty acid FFA: Free fatty ACID IGF-1R: IGF-1 receptor IGFBP: Insulin-like growth factor binding protein IRS: Insulin receptor substrate KO: Knock out LDL: Low density lipoprotein VLDL: Very low density lipoprotein GH: Growth hormone HOMA: Homeostasis model assessment ROS: Reactive oxygen species References Executive Summary of The Third Report of The
